Derwent London (LON:DLN) Stock Rating Kept at Credit Suisse; The GBX 3510.00 Target Indicates 13.96% Potential; Last Week IMS Health Holdings, Inc. (IMS) Coverage

June 16, 2018 - By Louis Casey

Derwent London Plc (LON:DLN) Logo

Among 7 analysts covering IMS Health Holdings Inc (NYSE:IMS), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. IMS Health Holdings Inc had 12 analyst reports since August 4, 2015 according to SRatingsIntel. Topeka Capital Markets maintained IMS Health Holdings, Inc. (NYSE:IMS) on Thursday, February 4 with “Buy” rating. Topeka Capital Markets maintained the shares of IMS in report on Friday, October 30 with “Buy” rating. The rating was downgraded by Wells Fargo on Thursday, May 12 to “Market Perform”. As per Wednesday, September 9, the company rating was maintained by Barclays Capital. The firm has “Outperform” rating given on Wednesday, February 24 by Leerink Swann. Mizuho maintained the shares of IMS in report on Friday, October 30 with “Buy” rating. The rating was maintained by Topeka Capital Markets on Monday, August 3 with “Buy”. See IMS Health Holdings, Inc. (NYSE:IMS) latest ratings:

In analysts note shared with investors and clients on Wednesday morning, Derwent London (LON:DLN) stock had its “Outperform” Rating maintained by stock analysts at Credit Suisse. They currently have a GBX 3510.00 PT on company. Credit Suisse’s target suggests a potential upside of 13.96% from the company’s last stock price.

The stock increased 0.00% or $0.99 during the last trading session, reaching $31.34. About 4.03M shares traded or Infinity% up from the average. IMS Health Holdings, Inc. (NYSE:IMS) has 0.00% since June 16, 2017 and is . It has underperformed by 12.57% the S&P500.

The stock decreased 0.03% or GBX 1 during the last trading session, reaching GBX 3063. About 455,652 shares traded or 42.45% up from the average. Derwent London Plc (LON:DLN) has 0.00% since June 16, 2017 and is . It has underperformed by 12.57% the S&P500.

Among 20 analysts covering Derwent London (LON:DLN), 7 have Buy rating, 4 Sell and 9 Hold. Therefore 35% are positive. Derwent London has GBX 4307 highest and GBX 3 lowest target. GBX 3201.63’s average target is 4.53% above currents GBX 3063 stock price. Derwent London had 201 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Hold” rating by Societe Generale given on Tuesday, July 5. Credit Suisse upgraded the shares of DLN in report on Wednesday, December 6 to “Outperform” rating. The firm earned “Neutral” rating on Wednesday, May 31 by JP Morgan. HSBC maintained the stock with “Hold” rating in Friday, September 30 report. Goldman Sachs maintained Derwent London Plc (LON:DLN) rating on Tuesday, February 9. Goldman Sachs has “Neutral” rating and GBX 3090 target. Jefferies maintained Derwent London Plc (LON:DLN) on Friday, November 27 with “Hold” rating. Goldman Sachs maintained the stock with “Buy” rating in Friday, November 11 report. The firm has “Hold” rating by Liberum Capital given on Thursday, May 5. The stock of Derwent London Plc (LON:DLN) has “Underperform” rating given on Wednesday, November 30 by BNP Paribas. JP Morgan maintained the stock with “Overweight” rating in Friday, November 13 report.

Derwent London plc, through its subsidiaries, engages in the property investment, refurbishment, redevelopment, and operation of properties in central London. The company has market cap of 3.42 billion GBP. The firm rents its properties for office and residential purposes. It has a 10.9 P/E ratio. It qualifies as a real estate investment trust for federal income tax purposes.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>